Ryukakusan Co.
Find sources: "Ryukakusan Co." – news · newspapers · books · scholar · JSTOR (October 2018) (Learn how and when to remove this message)
Find sources: "Ryukakusan Co." – news · newspapers · books · scholar · JSTOR (October 2018) (Learn how and when to remove this message)
- Machine translation, like DeepL or Google Translate, is a useful starting point for translations, but translators must revise errors as necessary and confirm that the translation is accurate, rather than simply copy-pasting machine-translated text into the English Wikipedia.
- Consider adding a topic to this template: there are already 1,518 articles in the main category, and specifying
|topic=will aid in categorization. - Do not translate text that appears unreliable or low-quality. If possible, verify the text with references provided in the foreign-language article.
- You must provide copyright attribution in the edit summary accompanying your translation by providing an interlanguage link to the source of your translation. A model attribution edit summary is
Content in this edit is translated from the existing Japanese Wikipedia article at [[:ja:龍角散]]; see its history for attribution. - You may also add the template
{{Translated|ja|龍角散}}to the talk page. - For more guidance, see Wikipedia:Translation.
35°41′44′′N 139°46′49′′E / 35.6954532°N 139.7802246°E / 35.6954532; 139.7802246
| Headquarters | |
Native name | 株式会社 龍角散 |
|---|---|
| Company type | Public KK |
| Industry | Pharmaceuticals |
| Founded | 1871; 154 years ago (1871) |
| Headquarters | Higashi-Kanda, Chiyoda, Tokyo101-0031, Japan |
Key people | Ryuta Fujii (President and CEO) |
| Products |
|
| Website | Official website |
Ryukakusan Co., Ltd. (株式会社 龍角散, Kabushiki-gaisha Ryukakusan) is a Tokyo-based Japanese pharmaceutical company that develops and markets prescription and over-the-counter drug (OTC) products, especially throat and swallowing products.[1]
History
[edit ]In the early 18th century, "Ryukakusan" was a powdered Kampo cough medicine produced by the Fuji family, physicians to the Satake Clan of the Akita Domain.[2] [3] [4] Literally "dragon antler powder", it was named after its ingredients: long gu ("dragon bone"), deer antler powder, and borneol. Shoteiji Fujii began selling it as medicine for the public in 1871. In 1894, his son Tokusaburo revised the formula, introducing the now-familiar herbal formulation in fine powder form.[5]
In 1995, the company had a \4 billion debt. They recovered from this by selling the Iatron Laboratory to Mitsubishi in 2002.[6]
Ryukakusan's products are popular in China and Taiwan. Tourists buy their products in bulk, to bring home, when they travel to Japan.[6]
China
[edit ]Ryukakusan exploded in popularity in China in 2015 after a post named it as a "miraculous drug" for relief from sore throat caused by air pollution. In 2016, a Chinese person was arrested in Japan for suspicion of illegally purchasing the drug for resale. In 2017, Taobao delisted a number of Japanese drugs, including Ryukakusan, for not having proper authorization. In 2019, a copycat product Ryu-no-san appeared in China.[7]
Products
[edit ]- Ryukakusan (herbal powder, class III OTC in Japan)
- Ryukakusan Direct (herbal powder and herbal troche for direct oral use without water, class III OTC in Japan)
- Ryukakusan Throat Refreshers (herbal lozenge, regular food in Japan)
- Swallowing Aid Jelly (herbal jelly, regular food in Japan)
References
[edit ]- ^ Ryukakusan (25 October 2018). "Ryukakusan" . Retrieved 25 October 2018.
- ^ "History of Ryukakusan|Ryukakusan Co., Ltd".
- ^ 【もとをたどれば】龍角散/秋田藩の薬 中国でも人気 Archived 2020年08月14日 at the Wayback Machine「毎日新聞」朝刊2019年9月15日(6面)2019年9月18日閲覧
- ^ "「龍角散」のふるさと秋田 健康を支えた家庭薬展". 秋田県市民活動情報ネット". Retrieved 2020年03月04日.
- ^ "龍角散|家庭薬ロングセラー物語|日本家庭薬協会". 日本家庭薬協会 (in Japanese). Archived from the original on 2022年01月20日. Retrieved 2021年08月29日.
ちなみに龍角散の薬名は、初期の処方に「龍骨」「鹿角霜」「龍脳」が使われたことに由来しています。
- ^ a b "Tourists' favorite throat remedy to get a big dose of investment". Nikkei Asian Review. Retrieved 2019年03月11日.
- ^ "中国人が神薬と呼ぶ「龍角散」人気の理由 | PM2.5対策への効果の期待が背景に". 訪日ラボ (in Japanese). 6 August 2019.
External links
[edit ]
This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it.